Pembrolizumab Wins FDA Approval in Operable Lung Cancer

(MedPage Today) -- The FDA approved pembrolizumab (Keytruda) on Monday in combination with platinum-based chemotherapy for the perioperative treatment of resectable non-small cell lung cancer (NSCLC). Approval was based on improved event-free...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news